EP3686193
2-(2,4,5-SUBSTITUTED-ANILINO)PYRIMIDINE COMPOUNDS
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
25.7.2012EP published:
2.3.2022EP application number:
20157798.8
EPO information:
European Patent Register
Max expiry date:
24.7.2032
Title in English:
2-(2,4,5-SUBSTITUTED-ANILINO)PYRIMIDINE COMPOUNDSLanguage of the patent:
English
Timeline
Today
25.7.2012EP application
2.3.2022EP Publication
Owner
Name:
Astrazeneca ABAddress:
151 85 Södertälje, SE
Inventor
Name:
BUTTERWORTH, SamAddress:
Macclesfield, Cheshire SK10 4TG, GB
Name:
WARD, Richard AndrewAddress:
Cambridge, Cambridgeshire CB4 0WG, GB
Name:
FINLAY, Maurice Raymond VerschoyleAddress:
Cambridge, CB4 0WG, GB
Name:
KADAMBAR, Vasantha, KrishnaAddress:
Macclesfield, Cheshire SK10 4TG, GB
Name:
CHINTAKUNTLA, Chandrasekhara, ReddyAddress:
Macclesfield, Cheshire SK10 4TG, GB
Name:
MURUGAN, AndiappanAddress:
Macclesfield, Cheshire SK10 4TG, GB
Name:
CHUAQUI, Claudio, EdmundoAddress:
Waltham, MA 02451, US
Name:
REDFEARN, Heather, MarieAddress:
Macclesfield, Cheshire SK10 2NA, GB
Priority
Number:
201161512061 PDate:
27.7.2011Country:
US
Number:
201261591363 PDate:
27.1.2012Country:
US
Classification
Categories:
C07D 401/02, C07D 471/04, A61K 31/506, A61K 31/437, A61P 35/00